Title 915 | Chapter 002 | Regulation 050
PREVIOUS VERSION
The previous document that this document is based upon is available.
915 KAR 2:050.Qualifying Medical Conditions.
Section 1.
The Definition of Qualifying Medical Condition.(1)
The definition of qualifying medical conditioncontained in KRS 218B.010(26) may encompass additional medical conditions if an underlying symptom of those conditions is:(a)
Expressly defined as a qualifying medical condition in KRS 218B.010(26); and(b)
Properly diagnosed by a medical cannabis practitioner or the medical cannabis practitioner properly confirms the diagnosis provided by another health care provider.(2)
The following list of medical conditions have been recommended for express inclusion within the definition of qualifying medical condition by the Kentucky Board of Physicians and Advisors and are recognized as having at least one (1) underlying symptom that is defined as a qualifying medical condition under KRS 218B.010(26):(a)
Amyotrophic Lateral Sclerosis;(b)
Parkinson's Disease;(c)
Crohn's Disease;(d)
Ulcerative Colitis;(e)
Sickle Cell Anemia;(f)
Cachexia or Wasting Syndrome;(g)
Neuropathies;(h)
Severe Arthritis;(i)
Fibromyalgia;(j)
Muscular Dystrophy;(k)
Huntington's Disease;(l)
Human Immunodeficiency Virus (HIV);(m)
Acquired Immunodeficiency Syndrome (AIDS);(n)
Glaucoma; and(o)
Terminal Illness.HISTORY: (915 KAR 002:050. 52 Ky.R. 105, 725; eff. 10-20-2026.)
FILED WITH LRC: September 9, 2026
CONTACT PERSON: Krista Quarles, Policy Analyst, Office of Legislative and Regulatory Affairs, 275 East Main Street 5 W-A, Frankfort, Kentucky 40621; Phone: 502-564-7476; Fax: 502-564-7091; CHFSregs@ky.gov.
915 KAR 2:050.Qualifying Medical Conditions.
Section 1.
The Definition of(1)
The definition of(a)
Expressly defined as a(b)
Properly diagnosed by a medical cannabis practitioner or the medical cannabis practitioner properly confirms the diagnosis provided by another health care provider.(2)
The following list of medical conditions have been recommended for express inclusion within the definition of(a)
Amyotrophic Lateral Sclerosis;(b)
Parkinson's Disease;(c)
Crohn's Disease;(d)
Ulcerative Colitis;(e)
Sickle Cell Anemia;(f)
Cachexia or Wasting Syndrome;(g)
Neuropathies;(h)
Severe Arthritis;(i)
Fibromyalgia;(j)
Muscular Dystrophy;(k)
Huntington's Disease;(l)
Human Immunodeficiency Virus (HIV);(m)
Acquired Immunodeficiency Syndrome (AIDS);(n)
Glaucoma; and(o)
Terminal Illness.HISTORY: (915 KAR 002:050. 52 Ky.R. 105, 725; eff. 10-20-2026.)
FILED WITH LRC: September 9, 2026
CONTACT PERSON: Krista Quarles, Policy Analyst, Office of Legislative and Regulatory Affairs, 275 East Main Street 5 W-A, Frankfort, Kentucky 40621; Phone: 502-564-7476; Fax: 502-564-7091; CHFSregs@ky.gov.